View in EDS

Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's disease.

Saved in:
Bibliographic Details
Title: Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's disease.
Authors: Barbosa RP; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Bastos P; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Béreau M; Département de Neurologie, CHU de Besançon, 25000, Besançon, France; Université de Franche-Comté, LINC Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive, 25000, Besançon, France., Rolland AS; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France., Rascol O; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Brefel-Courbon C; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Ory-Magne F; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., de Barros A; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France., Moreau C; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France., Hainque E; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, F-75013, Paris, France., Rouaud T; Department of Neurology, Nantes University Hospital, NS-PARK/FCRIN Network, Cedex, 44093, Nantes, France., Marques A; Université Clermont Auvergne, EA7280, Clermont-Ferrand University Hospital, Neurology Department, NS-PARK/FCRIN Network, 63000, Clermont-Ferrand, France., Eusebio A; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, France., Colin O; Service de Neurologie, Centre Hospitalier de Brive-la-Gaillarde, France; Centre Expert Parkinson, CHU de Limoges, France., Drapier S; Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, NS-PARK/FCRIN Network, Cedex, 35033, Rennes, France; Department of Neurology, Rennes University Hospital, CIC INSERM 1414, NS-PARK/FCRIN Network, Cedex, 35033, Rennes, France., Guehl D; CHU de Bordeaux, Centre Expert Parkinson, Institut des maladies Neuro-dégénératives, F-33000, Bordeaux, France., Maltete D; Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, NS-PARK/FCRIN Network, Mont-Saint-Aignan, France., Tranchant C; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, NS-PARK/FCRIN Network, Strasbourg, France., Giordana C; Service Universitaire de Psychiatrie, Hôpital Pasteur 1, CHU de Nice, Nice, France; Neurology Department, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Tir M; Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's disease, Amiens University Hospital, EA 4559, Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP), Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), NS-PARK/FCRIN Network, France., Thobois S; Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, CNRS, Institut des Sciences Cognitives, UMR, 5229, Bron, France; Centre Expert Parkinson, Hôpital Neurologique 'Pierre Wertheimer,', Hospices Civils de Lyon, NS-PARK/FCRIN Network, Lyon, France., Hopes L; Neurology Department, Nancy University Hospital, 54000, Nancy, France., Brandel JP; Hôpital Fondation Ophtalmologique A de Rothschild, Unité James Parkisnon, NS-PARK/FCRIN Network, F-75019, Paris, France., Jarraya B; Pôle Neurosciences, Foch Hospital, Suresnes, France; Université de Versailles Paris-Saclay, INSERM U992, CEA Neurospin, France., Corvol JC; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, F-75013, Paris, France., Devos D; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France., Fabbri M; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France. Electronic address: margheritafabbrimd@gmail.com.
Corporate Authors: PREDISTIM Group
Source: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2026 May; Vol. 146, pp. 108283. Date of Electronic Publication: 2026 Mar 19.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5126 (Electronic) Linking ISSN: 13538020 NLM ISO Abbreviation: Parkinsonism Relat Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41887013
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Barbosa+RP%22">Barbosa RP</searchLink>; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France.<br /><searchLink fieldCode="AU" term="%22Bastos+P%22">Bastos P</searchLink>; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France.<br /><searchLink fieldCode="AU" term="%22Béreau+M%22">Béreau M</searchLink>; Département de Neurologie, CHU de Besançon, 25000, Besançon, France; Université de Franche-Comté, LINC Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive, 25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Rolland+AS%22">Rolland AS</searchLink>; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Rascol+O%22">Rascol O</searchLink>; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France.<br /><searchLink fieldCode="AU" term="%22Brefel-Courbon+C%22">Brefel-Courbon C</searchLink>; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France.<br /><searchLink fieldCode="AU" term="%22Ory-Magne+F%22">Ory-Magne F</searchLink>; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France.<br /><searchLink fieldCode="AU" term="%22de+Barros+A%22">de Barros A</searchLink>; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France.<br /><searchLink fieldCode="AU" term="%22Moreau+C%22">Moreau C</searchLink>; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Hainque+E%22">Hainque E</searchLink>; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, F-75013, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rouaud+T%22">Rouaud T</searchLink>; Department of Neurology, Nantes University Hospital, NS-PARK/FCRIN Network, Cedex, 44093, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Marques+A%22">Marques A</searchLink>; Université Clermont Auvergne, EA7280, Clermont-Ferrand University Hospital, Neurology Department, NS-PARK/FCRIN Network, 63000, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Eusebio+A%22">Eusebio A</searchLink>; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS, France.<br /><searchLink fieldCode="AU" term="%22Colin+O%22">Colin O</searchLink>; Service de Neurologie, Centre Hospitalier de Brive-la-Gaillarde, France; Centre Expert Parkinson, CHU de Limoges, France.<br /><searchLink fieldCode="AU" term="%22Drapier+S%22">Drapier S</searchLink>; Behavior and Basal Ganglia' Research Unit (EA 4712), University of Rennes 1, Rennes, France; Department of Neurology, Rennes University Hospital, NS-PARK/FCRIN Network, Cedex, 35033, Rennes, France; Department of Neurology, Rennes University Hospital, CIC INSERM 1414, NS-PARK/FCRIN Network, Cedex, 35033, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Guehl+D%22">Guehl D</searchLink>; CHU de Bordeaux, Centre Expert Parkinson, Institut des maladies Neuro-dégénératives, F-33000, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Maltete+D%22">Maltete D</searchLink>; Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, NS-PARK/FCRIN Network, Mont-Saint-Aignan, France.<br /><searchLink fieldCode="AU" term="%22Tranchant+C%22">Tranchant C</searchLink>; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, NS-PARK/FCRIN Network, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Giordana+C%22">Giordana C</searchLink>; Service Universitaire de Psychiatrie, Hôpital Pasteur 1, CHU de Nice, Nice, France; Neurology Department, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.<br /><searchLink fieldCode="AU" term="%22Tir+M%22">Tir M</searchLink>; Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's disease, Amiens University Hospital, EA 4559, Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP), Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), NS-PARK/FCRIN Network, France.<br /><searchLink fieldCode="AU" term="%22Thobois+S%22">Thobois S</searchLink>; Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, CNRS, Institut des Sciences Cognitives, UMR, 5229, Bron, France; Centre Expert Parkinson, Hôpital Neurologique 'Pierre Wertheimer,', Hospices Civils de Lyon, NS-PARK/FCRIN Network, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Hopes+L%22">Hopes L</searchLink>; Neurology Department, Nancy University Hospital, 54000, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Brandel+JP%22">Brandel JP</searchLink>; Hôpital Fondation Ophtalmologique A de Rothschild, Unité James Parkisnon, NS-PARK/FCRIN Network, F-75019, Paris, France.<br /><searchLink fieldCode="AU" term="%22Jarraya+B%22">Jarraya B</searchLink>; Pôle Neurosciences, Foch Hospital, Suresnes, France; Université de Versailles Paris-Saclay, INSERM U992, CEA Neurospin, France.<br /><searchLink fieldCode="AU" term="%22Corvol+JC%22">Corvol JC</searchLink>; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, F-75013, Paris, France.<br /><searchLink fieldCode="AU" term="%22Devos+D%22">Devos D</searchLink>; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, F-59000, Lille, France.<br /><searchLink fieldCode="AU" term="%22Fabbri+M%22">Fabbri M</searchLink>; Department of Clinical Pharmacology, Physiology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, Toulouse, NS-PARK/FCRIN Network, France; ToNIC, Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France. Electronic address: margheritafabbrimd@gmail.com.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PREDISTIM+Group%22">PREDISTIM Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229513583%22">Parkinsonism & related disorders</searchLink> [Parkinsonism Relat Disord] 2026 May; Vol. 146, pp. 108283. <i>Date of Electronic Publication: </i>2026 Mar 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9513583 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-5126 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213538020%22">13538020 </searchLink><i>NLM ISO Abbreviation: </i>Parkinsonism Relat Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41887013
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.parkreldis.2026.108283
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108283
    Titles:
      – TitleFull: Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Barbosa RP
      – PersonEntity:
          Name:
            NameFull: Bastos P
      – PersonEntity:
          Name:
            NameFull: Béreau M
      – PersonEntity:
          Name:
            NameFull: Rolland AS
      – PersonEntity:
          Name:
            NameFull: Rascol O
      – PersonEntity:
          Name:
            NameFull: Brefel-Courbon C
      – PersonEntity:
          Name:
            NameFull: Ory-Magne F
      – PersonEntity:
          Name:
            NameFull: de Barros A
      – PersonEntity:
          Name:
            NameFull: Moreau C
      – PersonEntity:
          Name:
            NameFull: Hainque E
      – PersonEntity:
          Name:
            NameFull: Rouaud T
      – PersonEntity:
          Name:
            NameFull: Marques A
      – PersonEntity:
          Name:
            NameFull: Eusebio A
      – PersonEntity:
          Name:
            NameFull: Colin O
      – PersonEntity:
          Name:
            NameFull: Drapier S
      – PersonEntity:
          Name:
            NameFull: Guehl D
      – PersonEntity:
          Name:
            NameFull: Maltete D
      – PersonEntity:
          Name:
            NameFull: Tranchant C
      – PersonEntity:
          Name:
            NameFull: Giordana C
      – PersonEntity:
          Name:
            NameFull: Tir M
      – PersonEntity:
          Name:
            NameFull: Thobois S
      – PersonEntity:
          Name:
            NameFull: Hopes L
      – PersonEntity:
          Name:
            NameFull: Brandel JP
      – PersonEntity:
          Name:
            NameFull: Jarraya B
      – PersonEntity:
          Name:
            NameFull: Corvol JC
      – PersonEntity:
          Name:
            NameFull: Devos D
      – PersonEntity:
          Name:
            NameFull: Fabbri M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-5126
          Numbering:
            – Type: volume
              Value: 146
          Titles:
            – TitleFull: Parkinsonism & related disorders
              Type: main
ResultId 1